Outcome of patients with neuroblastoma aged less than 1 year at diagnosis |
Suh, Jung Min
(Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine)
Lee, Sang Goo (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Yoo, Keon Hee (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Sung, Ki Woong (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Koo, Hong Hoe (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Kim, Ju Youn (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Cho, Eun Joo (Department of Pediatric, Samsung Medical Center Sungkyunkwan University School of Medicine) Lee, Suk Koo (Department of Pediatric Surgery, Samsung Medical Center Sungkyunkwan University School of Medicine) Kim, Jhingook (Department of Thoracic Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine) Lim, Do Hoon (Department of Radiation Oncology, Samsung Medical Center Sungkyunkwan University School of Medicine) |
1 | Shimada H, Ambros IM, Dehner LP, Hata J, Joshi VV, Roald B, et al. The International Neuroblastoma Pathology Classification (the Shimada system). Cancer 1999;86:364-72 DOI ScienceOn |
2 | Kretschmar CS, Frantz CN, Rosen EM, Cassady JR, Levey R, Sallan SE. Improved prognosis for infants with stage IV neuroblastoma. J Clin Oncol 1984;2:799-803 |
3 | Matthay KK, Sather HN, Seeger RC, Haase GM, Hammond GD. Excellent outcome of stage II neuroblastoma is independent of residual disease and radiation therapy. J Clin Oncol 1989;7:236-44 |
4 | Joshi VV, Cantor AB, Brodeur GM, Look AT, Shuster JJ, Altshuler G, et al. Correlation between morphologic and other prognostic markers of neuroblastoma. A study of histologic grade, DNA index, N-myc gene copy number, and lactic dehydrogenase in patients in the Pediatric Oncology Group. Cancer 1993;71:3173-81 DOI ScienceOn |
5 | Schmidt ML, Lukens JN, Seeger RC, Brodeur GM, Shimada H, Gerbing RB, et al. Biologic factors determine prognosis in infants with stage IV neuroblastoma: A prospective Children's Cancer Group study. J Clin Oncol 2000;18:1260-8 ScienceOn |
6 | Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N- myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6 PUBMED ScienceOn |
7 | Look AT, Hayes FA, Nitschke R, McWilliams NB, Green AA. Cellular DNA content as a predictor of response to chemotherapy in infants with unresectable neuroblastoma. N Engl J Med 1984;311:231-5 ScienceOn |
8 | Miller RW, Young JL, Jr., Novakovic B. Childhood cancer. Cancer 1995;75:395-405 DOI ScienceOn |
9 | Kliegaman RM, Berhman RE, Jenson HB, Stanton BF. Nelson Textbook of pediatrics. 18 ed. Philadelphia: WB saunders Co, 2007:1619-730 |
10 | Annual Report of the Korea Central Cancer Registry 1998- 2002. [cited 2008 Aug 1]. Available from: http://ncc.re.kr/ manage/manage03_03.jsp |
11 | Matthay KK, Villablanca JG, Seeger RC, Stram DO, Harris RE, Ramsay NK, et al. Treatment of high-risk neuroblastoma with intensive chemotherapy, radiotherapy, autologous bone marrow transplantation, and 13-cis-retinoic acid. Children's Cancer Group. N Engl J Med 1999;341:1165-73 DOI ScienceOn |
12 | Look AT, Hayes FA, Shuster JJ, Douglass EC, Castleberry RP, Bowman LC, et al. Clinical relevance of tumor cell ploidy and N-myc gene amplification in childhood neuroblastoma: a Pediatric Oncology Group study. J Clin Oncol 1991; 9:581-91 |
13 | Evans AE, D'Angio GJ, Propert K, Anderson J, Hann HW. Prognostic factor in neuroblastoma. Cancer 1987;59:1853-9 DOI ScienceOn |
14 | Sung KW, Lee SH, Yoo KH, Jung HL, Cho EJ, Koo HH, et al. Tandem high-dose chemotherapy and autologous stem cell rescue in patients over 1 year of age with stage 4 neuroblastoma. Bone Marrow Transplant 2007;40:37-45 DOI ScienceOn |
15 | Shimada H, Chatten J, Newton WA, Jr, Sachs N, Hamoudi AB, Chiba T, et al. Histopathologic prognostic factors in neuroblastic tumors: definition of subtypes of ganglioneuroblastoma and an age-linked classification of neuroblastomas. J Natl Cancer Inst 1984;73:405-16 PUBMED |
16 | Coldman AJ, Fryer CJ, Elwood JM, Sonley MJ. Neuroblastoma: influence of age at diagnosis, stage, tumor site, and sex on prognosis. Cancer 1980;46:1896-901 DOI ScienceOn |
17 | Brodeur GM, Seeger RC, Schwab M, Varmus HE, Bishop JM. Amplification of N-myc in untreated human neuroblastomas correlates with advanced disease stage. Science 1984;224:1121-4 DOI PUBMED |
18 | Nickerson HJ, Nesbit ME, Grosfeld JL, Baehner RL, Sather H, Hammond D. Comparison of stage IV and IV-S neuroblastoma in the first year of life. Med Pediatr Oncol 1985;13: 261-8 DOI ScienceOn |
19 | London WB, Castleberry RP, Matthay KK, Look AT, Seeger RC, Shimada H, et al. Evidence for an age cutoff greater than 365 days for neuroblastoma risk group stratification in the Children's Oncology Group. J Clin Oncol 2005;23:6459-65 DOI ScienceOn |
20 | Perez CA, Matthay KK, Atkinson JB, Seeger RC, Shimada H, Haase GM, et al. Biologic variables in the outcome of stages I and II neuroblastoma treated with surgery as primary therapy: a Children's Cancer Group study. J Clin Oncol 2000;18:18-26 ScienceOn |
21 | Seeger RC, Brodeur GM, Sather H, Dalton A, Siegel SE, Wong KY, et al. Association of multiple copies of the N- myc oncogene with rapid progression of neuroblastomas. N Engl J Med 1985;313:1111-6 PUBMED ScienceOn |